Cingulate Stock Fundamentals
| CING Stock | USD 4.55 0.19 4.01% |
Cingulate fundamentals help investors to digest information that contributes to Cingulate's financial success or failures. It also enables traders to predict the movement of Cingulate Stock. The fundamental analysis module provides a way to measure Cingulate's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cingulate stock.
The Cingulate's current Interest Expense is estimated to increase to about 937 K, while Net Interest Income is forecasted to increase to (656.8 K). Cingulate | Select Account or Indicator |
Cingulate Company Shares Outstanding Analysis
Cingulate's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cingulate Shares Outstanding | 3.21 M |
Most of Cingulate's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cingulate is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cingulate Shares Outstanding Historical Pattern
Today, most investors in Cingulate Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cingulate's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cingulate shares outstanding as a starting point in their analysis.
Cingulate Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Cingulate Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Cingulate has 3.21 M of shares currently outstending. This is 98.22% lower than that of the Biotechnology sector and 96.99% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.44% higher than that of the company.
Cingulate Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cingulate's current stock value. Our valuation model uses many indicators to compare Cingulate value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cingulate competition to find correlations between indicators driving Cingulate's intrinsic value. More Info.Cingulate is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Cingulate's Return On Equity is most likely to increase significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cingulate by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cingulate Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cingulate's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cingulate could also be used in its relative valuation, which is a method of valuing Cingulate by comparing valuation metrics of similar companies.Cingulate is currently under evaluation in shares outstanding category among its peers.
Cingulate ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cingulate's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cingulate's managers, analysts, and investors.Environmental | Governance | Social |
Cingulate Fundamentals
| Return On Equity | -2.74 | ||||
| Return On Asset | -1.04 | ||||
| Current Valuation | 5.42 M | ||||
| Shares Outstanding | 3.21 M | ||||
| Shares Owned By Insiders | 3.30 % | ||||
| Shares Owned By Institutions | 1.71 % | ||||
| Number Of Shares Shorted | 152.98 K | ||||
| Price To Book | 1.26 X | ||||
| Gross Profit | (15.49 M) | ||||
| EBITDA | (22.95 M) | ||||
| Net Income | (23.53 K) | ||||
| Cash And Equivalents | 8.2 M | ||||
| Cash Per Share | 0.73 X | ||||
| Total Debt | 3.14 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 10.94 X | ||||
| Book Value Per Share | 6.82 X | ||||
| Cash Flow From Operations | (15.04 M) | ||||
| Short Ratio | 0.72 X | ||||
| Earnings Per Share | (43.22) X | ||||
| Target Price | 35.4 | ||||
| Number Of Employees | 13 | ||||
| Beta | -0.91 | ||||
| Market Capitalization | 14.62 M | ||||
| Total Asset | 3.49 M | ||||
| Retained Earnings | (92.94 M) | ||||
| Working Capital | 856.85 K | ||||
| Net Asset | 3.49 M |
About Cingulate Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cingulate's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cingulate using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cingulate based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 691.5 K | 858.3 K | |
| Cost Of Revenue | 670.4 K | 667.6 K |
Currently Active Assets on Macroaxis
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:Check out Cingulate Piotroski F Score and Cingulate Altman Z Score analysis. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.